Financial analysts and market research firms generally evaluate Oscar Health (OSCR) with a balanced mix of buy, hold, or selective recommendations rather than a unanimous strong buy consensus. While bullish analysts point to the company's rapid revenue scaling, improved operating leverage, and expanding footprint across individual health insurance markets as catalysts for long-term appreciation, conservative analysts remain cautious due to historical net losses, medical loss ratio fluctuations, and regulatory uncertainties. Prospective investors should review up-to-date institutional research reports and consider their individual risk tolerance before making any investment decisions.